Pharmaceutical

Solid tumours: CAR-T therapies’ Waterloo

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

May 30, 2025 - 06:00
Solid tumours: CAR-T therapies’ Waterloo
Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.
Read the original article

Tags:

Previous Article

The impact of drug pricing and reimbursement on the pharmaceutical industry

Next Article

Regeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilities

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

STAT+: Gilead to acquire CymaBay for $4.3 billion, addi...

Feb 13, 2024

STAT+: Key Republicans nix idea to give FDA new power to regulate CBD

STAT+: Key Republicans nix idea to give FDA new power t...

Jul 28, 2023

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

STAT+: FDA cracks down on websites that claim to sell c...

Feb 15, 2024